Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

Thomas W. Grunt, Christian Dittrich, Georg Krupitza et al.|International Journal of Cancer|1995

Cited by 70